The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

The Phase II segment is a randomised, double-blind, placebo-controlled study assessing ABCL635 efficacy in 80 postmenopausal ...

Clinical trials move through four structured phases, from safety testing to long-term effects. Adaptive, basket, and umbrella trials are making cancer research faster and more flexible. Molecular ...

Arvinas plans Phase 3 trials for vepdegestrant combinations in breast cancer and initiates trials for new Parkinson's disease treatments. Arvinas, Inc. announced its plans to begin two Phase 3 ...

The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study," was published in Obesity, the peer-reviewed ...

Clinical trials are vital for developing safer, more effective metastatic breast cancer treatments, yet participation is low due to access and financial barriers. Trials progress through phases, from ...

MIAMI LAKES, Fla.--(BUSINESS WIRE)--Segal Trials, a privately held clinical research network specializing in acute schizophrenia and other psychiatric disorders, has released enrollment performance ...

Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral ...

TROPION-Lung17 will enroll approximately 400 patients across global sites. Participants are randomized 1:1 to receive either ...

Clinical trial evaluating changes in urine protein-to-creatinine ratio, a widely-accepted endpoint measuring risk reduction of kidney failureCAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Akebia ...

Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most ...

The new rules introduce a fast-track notification route, enabling quicker starts for lower-risk trials and maintaining safety ...